Lemonade/$LMND
1D1W1MYTD1Y5YMAX
Capital at risk
About Lemonade
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.
- Ticker
- $LMND
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 1,282
- Headquarters
- New York, United States
- Website
- www.lemonade.com
Lemonade Metrics
BasicAdvanced
$3.5B
-
-$1.83
1.86
-
Price and volume
Market cap
$3.5B
Beta
1.86
52-week high
$99.90
52-week low
$43.28
Average daily volume
1M
Financial strength
Current ratio
1.304
Quick ratio
0.908
Long term debt to equity
0.453
Total debt to equity
0.413
Interest coverage (TTM)
-6.31%
Profitability
EBITDA (TTM)
-98
Gross margin (TTM)
51.65%
Net profit margin (TTM)
-14.19%
Operating margin (TTM)
-11.19%
Effective tax rate (TTM)
-3.83%
Revenue per employee (TTM)
$760,000
Management effectiveness
Return on assets (TTM)
-3.46%
Return on equity (TTM)
-26.96%
Valuation
Price to revenue (TTM)
3.487
Price to book
6.96
Price to tangible book (TTM)
7.35
Price to free cash flow (TTM)
419.781
Free cash flow yield (TTM)
0.24%
Free cash flow per share (TTM)
0.107
Growth
Revenue change (TTM)
62.31%
Earnings per share change (TTM)
-35.13%
3-year revenue growth (CAGR)
39.11%
3-year earnings per share growth (CAGR)
-24.14%
What the Analysts think about Lemonade
Analyst ratings (Buy, Hold, Sell) for Lemonade stock.
Analyst projections of the future price of Lemonade stock.
Bulls say / Bears say
Lemonade is still expanding rapidly: in-force premium rose 32.4% year on year to $1.43 billion, marking an 11th consecutive quarter of accelerating growth. Customers increased 23%, while premium per customer rose 8%, suggesting growth is coming from both scale and greater customer value. (Lemonade, Longbridge)
Lemonade is showing a credible route towards profitability and stronger capital efficiency. The adjusted EBITDA loss narrowed 54% to $18.7 million, adjusted free cash flow was positive for a fifth consecutive quarter, and lower quota-share cessions mean the company retains more premium while adding catastrophe protection. (Lemonade, The Motley Fool)
Lemonade remains loss-making: Q2 net loss was $43.4 million and adjusted EBITDA was negative $18.7 million. Operating expenses excluding claims rose 41% to $182.2 million, while full-year 2026 guidance still implies an adjusted EBITDA loss of $47–51 million. (Lemonade, Longbridge)
The 60% gross loss ratio was helped by seven percentage points of favourable prior-period development, so it may overstate underlying underwriting improvement. Product risks also remain uneven, with Q2 gross loss ratios of 74% for pet insurance and 71% across Europe. (Last10K, Seeking Alpha)
Lemonade’s growth still consumes capital and carries catastrophe risk. Management arranged $250 million of synthetic-agent financing at about 9.8%, while high growth requires additional insurance surplus and the new catastrophe protection remains subject to event and aggregate limits. (MarketBeat, Lemonade)
Data summarised monthly by Lightyear AI. Last updated on 21 Sept 2026.
Lemonade Financial Performance
Revenues and expenses
Lemonade Earnings Performance
Company profitability
Upcoming events
No upcoming events
Lemonade News
AllArticlesVideos
Funds containing Lemonade
AllEURGBPUSD
Fund name | Fund size | $LMND weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.11% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.05% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.05% |
iShares MSCI World Small Cap$WSML | $9B | 0.03% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.